Intelligence Feed event · Equity · 2026-10-10

    DaVita Gains 1.3% to $179.25 with Q3 EPS Projected Up 50.6% YoY

    Question

    DaVita Gains 1.3% to $179.25 with Q3 EPS Projected Up 50.6% YoY

    Direct answer

    DaVita HealthCare gained 1.26% to close at $179.25, demonstrating positive relative strength versus broader equity benchmarks. The healthcare provider continues to benefit from steady outpatient treatment volumes. Consensus estimates project upcoming quarter EPS growth of 50.60% on 3.23% higher revenue, with full-year EPS expansion estimated at 35.16%. The equity currently trades at a forward price-to-earnings multiple of 12.15.

    Original publisher
    Market Ontology
    Evidence through
    2026-10-10
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “DaVita Gains 1.3% to $179.25 with Q3 EPS Projected Up 50.6% YoY”, revision 1, evidence through 2026-10-10. https://marketontology.com/market-events/2026-10-10/davita-gains-1-3-to-179-25-with-q3-eps-projected-up-50-6-yoy-8987d4

    EQUITY
    DaVita Gains 1.3% to $179.25 with Q3 EPS Projected Up 50.6% YoY
    DaVita HealthCare gained 1.26% to close at $179.25, demonstrating positive relative strength versus broader equity benchmarks. The healthcare provider continues to benefit from steady outpatient treatment volumes. Consensus estimates project upcoming quarter EPS growth of 50.60% on 3.23% higher revenue, with full-year EPS expansion estimated at 35.16%. The equity currently trades at a forward price-to-earnings multiple of 12.15.
    DVA
    Impact
    64
    OCT 10
    SIG
    84%
    DVA
    DaVita Gains 1.3% to $179.25 with Q3 EPS Projected Up 50.6% YoY
    DaVita HealthCare gained 1.26% to close at $179.25, demonstrating positive relative strength versus broader equity benchmarks. The healthcare provider continues to benefit from steady outpatient treatment volumes. Consensus estimates project upcoming quarter EPS growth of 50.60% on 3.23% higher revenue, with full-year EPS expansion estimated at 35.16%. The equity currently trades at a forward price-to-earnings multiple of 12.15.
    → Operating leverage from specialized outpatient dialysis center utilization drives DaVita's projected 50.60% EPS expansion at a 12.15 forward earnings multiple.
    Impact
    DaVita HealthCare gained 1.26% to close at $179.25, demonstrating positive relative strength versus broader equity benchmarks. The healthcare provider continues to benefit from steady outpatient treatment volumes. Consensus estimates project upcoming quarter EPS growth of 50.60% on 3.23% higher revenue, with full-year EPS expansion estimated at 35.16%. The equity currently trades at a forward price-to-earnings multiple of 12.15.
    Affected
    DVA
    Transmission
    Operating leverage from specialized outpatient dialysis center utilization drives DaVita's projected 50.60% EPS expansion at a 12.15 forward earnings multiple.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    DVAoutpatient dialysis treatment volume growth and cost containmentUp1-4w1.26% gain to $179.25 on consensus 50.60% quarterly EPS expansion projection.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month